MNAT1 and myeloid leukemia: Furthermore, in myeloid leukemia cells, retinoic acid (RA)-induced MAT1 fragmentation at amino acid 229 suppresses CAK phosphorylation and leads to cell cycle arrest, suggesting a novel therapeutic potential of the C-terminal protein fragment against different subtypes of myeloid leukemia [30].